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1. Introduction 
Rat kidney contains two distinct glutaminase activ- 
ities;a mitochondrial phosphate-dependent glutaminase 
and a phosphate-independent, but maleate-stimulated 
glutaminase [ 11. The latter reaction is an activity of 
the brush border membrane-associated y-glutamyl- 
transpeptidase [2,3]. Assays specific for each gluta- 
minase activity were devised by taking advantage of 
their differences in activators and pH optima [4]. 
However, rat renal glutaminase activity has frequently 
been quantitated using conditions where the relative 
contribution of the two activities is uncertain. The 
availability of an inhibitor specific for one of the two 
glutaminase activities would greatly facilitate the 
assessment of the specificity of various assay condi- 
tions. 
Phosphate-dependent glutaminase was purified 
from acidotic rats [9] and stored as a 1-2 mg/ml 
suspension in 10 mM sodium borate, 100 mM potas- 
sium phosphate, 100 mM potassium pyrophosphate 
buffer (pH 8.6). Before use in various experiments, 
the enzyme was dialyzed against two l- 1 changes of 
10 mM Tris-acetate, 1 mM dithiothreitol buffer (pH 
8.6). Glutaminase activity was determined by using 
glutamate dehydrogenase to quantitate glutamate for- 
mation [lo]. 
AT-125 [L-(OLS, 5S)-a-amino-3-chloro-4,5-dihydro- 
5-isoxazoleacetic acid] is a glutamine antagonist which 
inactivates various glutamine amidotransferases [5] 
and glutaminases [6]. Rat renal y-glutamyltranspep- 
tidase is also rapidly and irreversibly inactivated by 
low concentrations of AT-125 [7,8]. In contrast, the 
phosphate-dependent glutaminase activity was found 
to be completely resistant to inactivation by AT-125. 
Therefore, this inhibitor can be used to determine the 
specificity of various in vitro glutaminase assays and 
to establish the in vivo contribution ofy-glutamyltrans- 
peptidase to rat renal amtnonia excretion. 
y-Glutamyltranspeptidase was purified following 
its solubilization with papain [ 1 11. The transpeptidase 
activity was determined using either y-glutamyl-p- 
nitroanilide [3] or as phosphate-independent glut- 
aminase activity [4]. Glutaminase activity was also 
determined in crude homogenates using either 50 mM 
Tris--HCl, 10 mM glutamine and 50 mM sodium male- 
ate (pH 8.0) [3] or 10 mM Hepes, 2 mM glutamine 
(pH 7.4) as the initial reaction mixture. After incubat- 
ing for 10 min at 37°C the reaction was stopped by 
heating to 90°C for 2 min and the glutamate produced 
was then quantitated using glutamate dehydrogenase 
[lo]. Protein was determined by the method of Lowry 
[ 121. Plasma glutamine [ 131 and urinary ammonia 
[ 141 concentrations were determined as described. 
3. Results 
2. Materials and methods 
White male rats (100-200 g) were obtained from 
Zivic Miller and were maintained on Purina Rat Chow. 
AT-125 was kindly provided by Dr Ruth Davis of the 
National Cancer Institute. 
When purified y-glutamyltranspeptidase is incu- 
bated at 25’C with 0.1 tnM AT-1 25, its activity 
decreases with first order kinetics and a fl,* of 7 min. 
The inactivated transpeptidase failed to utilize either 
y-glutamyl-p-nitroaniline or glutamine as a substrate. 
In contrast, as shown in table 1, incubation of purified 
phosphate-dependent glutaminase for 30 min at 25°C 
with up to 10 mM AT-125 resultsin nolossofactivity. 
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Table 1 
Effect of AT-125 on the activity of purified rat renal 
phosphatedependent glutaminase 
Samples -Pi +Pi 
(pm01 . mind’. ml-‘) 
Control 11.4 14.1 
+ 0.3 mM AT-l 25 11.7 14.2 
+lO mM AT-125 11.2 14.1 
Aliquots of purified phosphate-dependent glutaminase con- 
taining 10 c(g protein were diluted into 100 bl 10 mM Tris- 
HCl buffer (pH 8.6) containing either no phosphate (-Pi) or 
150 mM potassium phosphate (+Pi) and the indicated concen- 
trations of AT-125. After incubating at 25°C for 30 min, the 
samples were assayed for phosphatedepcndent glutaminase 
activity 
Since inactivation of phosphate-dependent glutamin- 
ase with 6-diazo-5-oxo-L-norleucine occurs only in 
the presence of phosphate [ 151, the incubations with 
AT-125 were repeated in the presence of sufficient 
phosphate to promote complete conversion of the 
glutaminase to its active dirneric conformation. Even 
under these conditons, the glutaminase was completely 
resistant to inactivation by AT-125. 
Because of the selective inhibition of y-glutamyl- 
transpeptidase by AT- 125 this agent should provide 
an effective criterion of the specificity of assays which 
quantitate glutamine hydrolysis activity in crude 
homogenates of kidney tissue. As shown in table 2, 
preincubation of a crude homogenate of normal kid- 
ney tissue with AT-1 25 results in complete inactiva- 
tion of the transpeptidase activity determined with 
either y-glutamyl-p-nitroanilide or the assay for phos- 
phate-independent glutaminase activity. However, 
-30% of both the glutaminase activity measured at 
pH 7.4 in the absence of exogenous activator and the 
maleate-stimulated glutaminase activity measured at 
pH 8.0 are resistant to inactivation by AT-I 25. There- 
fore. activitiesin addition toy-glutamyltranspeptidase 
contribute significantly to the total glutaminase activ- 
ity measured under the latter two conditions. 
The observed difference in reactivity suggested that 
injection of AT-125 may result in selective in vivo 
inactivation of y-glutamyltranspeptidase. As shown in 
table 3, within 1 h after injection of 8- 10 mg AT-1 25/ 
kg body wt, 95% of the total renal y-glutamyltrans- 
peptidase activity is inactivated. In contrast, the injec- 
tion of AT-125 had no effect on the total renal phos- 
phate-dependent glutaminase activity. When a set of 
AT-125-treated rats were made acutely acidotic, the 
observed increase in ammonia excretion was not sig- 
nificantly different from that observed with non- 
Table 3 
Selective in vivo inhibition of y-glutamyltranspeptidase by 
injection of AT-1 25 
-____ 
Animals Phosphate-dependent y-glutamyl- 
glutaminase transpeptidase 
(nmol min-’ . mg-‘) 
Control 
+AT-125 
104 * 5 1230 ?- 78 
107 ?6 66+ 8 
Two groups of five 100-120 g rats were injected intraperi- 
toneally with either 0.5 ml saline (control) or 0.5 ml saline 
containing 1 mg AT-l 25 (+AT-125). After 1 h, the animals 
were decapitated and the kidneys excised and homogenized 
in 8 vol. 0.33 M sucrose, 20 mM Tris-HCI, 0.2 mM EDTA 
buffer (pH 7.5). The crude homogenates were then assayed 
for phosphate-dependent glutaminase and y-glutamyltrans- 
peptidase activities and for protein. The values reported are 
the mean + SE 
Table 2 
Use of AT-125 to determine the specificity of glutaminase assays applied to crude 
homogenates of normal rat kidney 
Homogenate +Jutamyl- 
transpeptidase 
activity 
Glutaminase activity (nmol . mine’. rng-‘) 
PIG Gln (pH 7.4) Gin (pH 8.0) 
+maleate 
Control 
+AT-I 25 
1320 f 230 70 f 4 3.1 f 0.3 83 ? 3 
<lO <l 0.9 f 0.2 23* 1 
Aliquots of three crude homogenates were incubated for 30 min at 25’C in the pres- 
ence or absence of 1 mM AT-125 and then assayed for r-glutamyltranspeptidase 
activity using r-glutamyl-p-nitroanilide and for glutaminase activity using the condi- 
tions described for phosphate-independent glutaminase (PIG) or the conditions in 
section 2. The values reported are the mean f SE 
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Table 4 
Effect of in vivo inhibition of y-glutamyltranspeptidase on renal adaptation to 
acute acidosis 
_ 
Animals Plasma Urine Urine y-Glutamyltrans- 
[ Glu tamine] (PH) [NH,+1 peptidase act. 
(mM) &mol/lOO g .4 h) (nmol/min-’ . mg-‘) 
Normal 0.469 ? 0.023 1.4 + 0.21 34? 1 1230 f 80 
Acute 
acidosis 0.696 + 0.013 5.7 + 0.02 185 f 16 1120r40 
+AT-125 0.648 r 0.044 5.6 + 0.08 209 * 28 II+ 6 
Two groups of six loo-120 g rats were injected with saline or AT-125 as in table 3. 
After 1 h, the animals were stomach-loaded with 20 wmol NH,Cl/kg and retained in 
metabolism cages for 4 h to permit collection of urine. After this, the rats were anes- 
thetized and arterial blood and the kidneys were withdrawn for glutamine and y-glut- 
amyltranspeptidase measurements, respectively. The normal controls received only 
the saline injection. The values reported are the mean f SE 
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inhibited, but acutely acidotic control animals (table 
4). In addition, injection of AT-125 had no effect on 
the observed increase in plasma glutamine concentra- 
tion or the acidification of the urine that are associated 
with onset of acute acidosis. However, the total trans- 
peptidase activity in the AT-l 25 treated rats was only 
7% of that observed in the controls. 
4. Discussion 
The data reported in this study indicate that 
AT- 125 can be used to inactivate y-glutamyltranspep- 
tidase without effecting the phosphate-dependent 
glutaminase activity. It is thus possible to use this 
inhibitor to determine the relative contribution of the 
two activities to glutamine metabolism observed in 
crude homogenates of rat kidney tissue. The inhibitor 
should be equally effective in experiments using kid- 
ney slices or isolated renal tubules. Because of this 
specificity, AT- 125 will also produce in vivo a selec- 
tive inhibition of y-glutamyltranspeptidase. 
The observation that the activity measured in crude 
homogenates under the conditions originally developed 
to quantitate phosphate-independent glutaminase 
activity [4] is completely inhibited by AT- 125 indi- 
cates that this assay is specific for the glutaminase 
activity due to y-glutamyltranspeptidase. Therefore, 
even though the activity observed under these condi- 
tions is less than maximal, the high degree of speci- 
ficity offered by these conditions make them more 
suitable for detecting the presence of glutaminase 
activity which is due to y-glutamyltranspeptidase. 
The lack of specificity observed with maleate at pH 
8.0 is probably due to the fact that maleate will sub- 
stitute for phosphate in activating the phosphate- 
dependent glutaminase [4]. 
On the basis of reports that y-glutamyltranspep- 
tidase activity is increased in response to chronic meta- 
bolic acidosis [ 16,171, it has been proposed that this 
enzyme may contribute to renal ammonia synthesis. 
We have confirmed that the specific activity of y-glut- 
amyltranspeptidase, assayed with y-glutamyl-p- 
nitroanilide, is slightly, but significantly increased 
(1.3-fold) during prolonged acidosis. This increased 
activity is retained throughout a lo-fold purification 
of brush border membrane vesicles. However, we 
found that the specific activity of alkaline phosphatase 
is also increased slightly in both crude homogenates 
and isolated brush border membranes derived from 
acidotic rats. Therefore, this adaptation may result 
from the generalized renal hypertrophy which occurs 
in response to chronic acidosis [ 181. The observed 
adaptation in transpeptidase activity is very small in 
comparison to the 20-fold increase in phosphate- 
dependent glutaminase activity which occurs in the 
proximal convoluted tubules during chronic acidosis 
[4]. The results reported here indicate that y-glut- 
amyltranspeptidase activity is not essential to elicit 
the adaptive increase in ammonia synthesis observed 
with onset of acidosis. 
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